Obidiugwu Kenrik Duru, MD, MSHS, discusses the prevalence, assessment and treatment of acute and chronic low back pain. This session was originally presented at IMM 2019.
This content is supported by an independent education grant funded by Pfizer, Inc., in partnership with Lilly USA, LLC.
Disclosures
Relevant financial relationships are disclosed below each name. Those with nothing listed have nothing to disclose.
2019 Internal Medicine Scientific Program Planning Committee
- Rachel P. Brook, MD, Member
- Robert K. Cato, MD, FACP
- Daniel D. Dressler, MD, MSc, FACP, SFHM
- Stephanie S. Faubion, MD, NCMP, IF, FACP
- Consultantship: Mithra Pharmaceuticals, Proctor & Gamble
- Jonathan Hogan, MD
- Gregory C. Kane, MD, MACP
- Lillian F. Lien, MD, FACP
- Consultantship: Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
- Eileen Moser, MD, MACP
- Stock Options/Holdings: Intuitive Surgical
- Lawrence M. Phillips, MD, FACP
- Speakers Bureau: Astellas Pharma
- Other: Merck
- William D. Surkis, MD, FACP
- Banu E. Symington, MD, MACP
- Michael J. Tan, FACP
- Speakers Bureau: Pfizer, Merck, Allergen, The Medicines Company
- Alexandra S. Villa‐Forte, MD, FACP
- Soma Wali, MD, MACP
- Patrick E. Young, MD, FACP, FACG, FASGE
Faculty/Speaker
- Obidiugwu Kenrik Duru, MD, MSHS